Feng Yang
@FengYang_MedBio
Followers
76
Following
307
Media
3
Statuses
113
Passion: cancer research, educating researchers, making discoveries, and turning discoveries into effective therapies for patients. #MAPK4. Opinions are my own.
Joined February 2021
🚨SB17 / HB17 would effectively ban citizens of China, Iran, North Korean + Russia from owning or leasing property in TX, unless they are US citizens or permanent residents. The bill would make it harder to recruit + retain grad students + professors. ⬇️
texasracistbills.org
Introducing racist bills in the current session of Texas legislature and how to fight them
1
8
12
We want to focus on Science. However, removing students, postdocs, and other researchers from certain countries will have devastating consequences on scientific research. It is also clearly racist behavior no matter how people decorate it. This is insane!
🚨SB17 / HB17 would effectively ban citizens of China, Iran, North Korean + Russia from owning or leasing property in TX, unless they are US citizens or permanent residents. The bill would make it harder to recruit + retain grad students + professors. ⬇️
0
0
1
Now online in @CD_AACR: Botensilimab, an Fc-enhanced anti-CTLA-4 Antibody, Is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy - by @dhanschand and colleagues https://t.co/10gt8q7Ou4
@Agenus_Bio
1
9
33
Officials from Baylor College of Medicine, @StLukesHealthTX, @BiVACOR and @Texas_Heart discuss the first-in-human total artificial heart implanted inside patient in Houston. https://t.co/tg1A15Red2
#HeartFailure #ArtificialHeart
click2houston.com
“This is a big day for all of us and one that was... probably 22 years in the making,” said Dr. William “Billy” Cohn from the Texas Heart Institute and Chief Medical Officer of BiVACOR.
3
18
36
Immune Checkpoint Inhibitors Show Effectiveness in Metastatic Colorectal Cancer | Dana-Farber Cancer Institute
blog.dana-farber.org
A combination of checkpoint inhibitors shows promising results in treating metastatic colorectal cancer, marking a potential breakthrough.
0
0
0
Bot/Bal #immunotherapy in #coloncancer #NEST 1/2 @Agenus_Bio with very promising data in early MSI-s/MSI-H #coloncancer ! @myESMO #ESMOGI24 #ESMOAmbassadors @OncoAlert #CancerResearch #cancer
4
23
78
🆕🗞️Just out 🪺#NEST-1 trial results👇🏾 Are we on the verge of a new drug combo for colon or rectal cancer? Substantial & brisk responses to just☝🏾dose of BOT🟢➕BAL🔹🔹 immunotherapy.🙌🏾 Pattern & kill is unprecedented🌊. @ASCO #GI24 @OncoAlert Abstract 117📍Poster Board H2
58
111
555
We've advanced RNA sequencing analysis for cancer cell lines with the Pan-cancer Cell Line Transcriptome Atlas (PCTA) dataset—a user-friendly platform. Explore at https://t.co/0SQCQHFKfp and read the manuscript https://t.co/pvdhMoFAjJ.
#CancerResearch #DataScience #PCTA
4
12
34
Using #TNBC cell models, Dr. Feng Yang (@FengYang_MedBio) and colleagues show that MAPK4 can also enhance PDK1 protein synthesis, thus phosphorylate/activate PDK1 substrates beyond AKT. @BCMFromtheLabs @bcmhouston 📖 Read the full story in @PLOSBiology. https://t.co/iNCwG4SN4w
0
4
3
.@FengYang_MedBio &co show that #MAPK4 promotes PDK1 protein synthesis and thus also activates PDK1 substrates beyond AKT to promote #cancer. Co-targeting AKT & PDK1 may help treat MAPK4-high cancers like "#TripleNegative" #BreastCancer #PLOSBiology
https://t.co/DAbw1NkCmZ
0
2
10
Our latest study on targeting MAPK4 in cancers/TNBC, a research field we pioneered.
The @FengYang_MedBio lab et al found a novel strategy to suppress triple negative #breastCancer growth. https://t.co/5t2jg9Q1Bz
@PLOSBiology @bcmhouston #research #MAPK4 @AKT @CPRITTexas @NIH
0
2
7
It's #MensHealthMonth! Learn about the progress on a novel strategy to suppress #prostateCancer growth. Dr. F Yang @FengYang_MedBio explains. @PNASNews @BCMCancerCenter
https://t.co/yWQUJj5iyq via @bcmhouston
0
4
7
Happy to see our most recent work got noticed; ranked top five. A surprise birthday gift by the readers.
What a better way to close 2022 than to see the top five most viewed posts of the year! @DrRosengart @shyamkavuri @RashiKalra49 @ThINKSavatic @DamianYoung29 @RosenbergLabBCM @FengYang_MedBio @BCMGradSchool @BCM_Alumni @BCMCancerCenter
https://t.co/lznPrN2zOX via @bcmhouston
0
0
8